Why Ozempic keeps wowing the world
GLP-1 drugs were first approved to treat diabetes and then caused a frenzy when it was discovered they were great for weight loss.
But now scientists are discovering the drugs that have brand names including Ozempic and Mounjaro might offer so much more, from reducing the risk of heart attack to treating kidney disease.
Today, Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University on how Ozempic is shaking things up, again.
Featured:
Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.